Physician profile
Dan K Eidman
NPI 1649270059
$6,471.59
in general payments reported to CMS, 2019-2025
18 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $907 · 2020: $3,340 · 2021: $1,724 · 2022: $97.51 · 2023: $162 · 2024: $110 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $403.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $402.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyocera Medical Technologies, INC. | $4,995.22 | 2019-2021 | |
| Heraeus Medical, LLC. | $456.40 | 2019-2022 | |
| Horizon Therapeutics Plc | $277.18 | 2019-2022 | |
| Pfizer INC. | $122.48 | 2023 | |
| Renovis Surgical Technologies, INC. | $121.62 | 2019 | |
| Life Spine, INC. | $94.05 | 2021 | |
| Sk Life Science, INC. | $89.02 | 2024-2025 | |
| Next Science LLC | $73.33 | 2021 | |
| Ossur Americas, INC. | $41.90 | 2024-2025 | Unloader One X, Miami J |
| Ucb, INC. | $39.60 | 2023 | Briviact |
| Acadia Pharmaceuticals INC | $25.09 | 2024 | Nuplazid |
| Otsuka America Pharmaceutical, INC. | $23.52 | 2024 | Nuedexta |
| Harmony Biosciences LLC | $22.98 | 2024 | |
| Biogen, INC. | $21.39 | 2025 | Vumerity, Tysabri |
| Kowa Pharmaceuticals America, INC. | $19.66 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Assertio Therapeutics, INC. | $17.89 | 2020 | |
| Abbvie INC. | $16.67 | 2025 | |
| Spineology INC. | $13.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dan Eidman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.